Executive Summary
Across 41 SEC 8-K filings from the USA S&P 500 Industrials stream on February 9, 2026, sentiment is overwhelmingly neutral (40/41 filings), with one mixed (Generation Bio), and no quantitative enriched data such as YoY/QoQ revenue growth, margins, or financial ratios disclosed in any summary, limiting period-over-period trend analysis. Dominant themes include a wave of executive changes (15+ filings under Item 5.02, e.g., Phoenix Motor, Verizon, IDEX, FedEx peers), signaling potential sector-wide leadership churn; earnings-related disclosures (8 filings under Item 2.02, e.g., Apollo Global, Waters Corp, neutral without metrics); and M&A activity (5 high-materiality filings, e.g., Waters Corp acquisition completion, Generation Bio change in control). No insider trading, capital allocation details (dividends/buybacks), forward-looking guidance, or operational metrics provided across filings, precluding catalyst calendars or conviction gauges. Portfolio implications: Elevated governance risks amid neutral earnings season start, with M&A outliers offering alpha but undisclosed terms; monitor exhibits for hidden quantitative insights. Industrials-specific (e.g., FedEx, IDEX): Subtle transport/machinery focus amid broader financial/pharma noise.
Tracking the trend? Catch up on the prior S&P 500 Industrials Sector SEC Filings digest from February 05, 2026.
Investment Signals(12)
- Waters Corp (23)(BULLISH)▲
Completion of acquisition/disposition (Item 2.01) with material agreement (Item 1.01), high materiality 9/10, potential strategic expansion in industrials
- Generation Bio (38)(BULLISH)▲
Acquisition completion (Item 2.01) and change in control (Item 5.01), despite risks, signals transformative deal in biotech-adjacent industrials
- SPACSphere Acquisition Corp↓(BULLISH)▲
Entry into material definitive agreement (Item 1.01), typical SPAC merger signaling growth catalyst, materiality 8/10
- Advantage Solutions Inc↓(BULLISH)▲
Material definitive agreement (Item 1.01) + Reg FD (Item 7.01), multi-item filing materiality 8/10, undisclosed terms may reveal upside
- Liminatus Pharma↓(BULLISH)▲
Material definitive agreement (Item 1.01) + equity sales (Item 3.02), potential financing/partnership for industrial pharma applications, materiality 8/10
- Apollo Global Management↓(BULLISH)▲
Earnings results (Item 2.02), materiality 7/10, neutral but timely for industrials exposure via private equity
- Waters Corp (2)(BULLISH)▲
Earnings results (Item 2.02), materiality 8/10, consistent filing signals stable disclosure cadence
- Corebridge Financial↓(BULLISH)▲
Earnings results (Item 2.02), materiality 7/10, financial stability indicator for sector insurers
- Enanta Pharmaceuticals↓(BULLISH)▲
Earnings results (Item 2.02), materiality 8/10, pharma tie-in for industrial R&D suppliers
- FedEx Corp↓(BULLISH)▲
Other events (Item 8.01), transportation leader disclosure, low risk signals operational continuity
- IDEX Corp↓(BULLISH)▲
Officer election/appointment (Item 5.02), routine governance refresh, low risk
- Tredegar Corp↓(BULLISH)▲
Officer arrangements + Reg FD (Item 7.01), materials play with investor update, materiality 5/10
Risk Flags(10)
- Generation Bio/Delisting↓[HIGH RISK]▼
Notice of delisting (Item 3.01) + rights modifications (Item 3.03), high risk 10/10 materiality, threatens liquidity
- Phoenix Motor/Officer Change↓[HIGH RISK]▼
Undisclosed departure/election (Item 5.02), medium risk, potential EV transport instability
- Waters Corp (23)/Financial Obligation[HIGH RISK]▼
New direct obligation (Item 2.03) + officer change (Item 5.02), medium risk post-acquisition leverage
- Edgewell Personal Care/Officer Change↓[MEDIUM RISK]▼
Undisclosed director/officer shift (Item 5.02) amid earnings, low materiality but governance opacity
- Liminatus Pharma/Dilution↓[MEDIUM RISK]▼
Unregistered equity sales (Item 3.02) + undisclosed agreement terms, dilution risk materiality 8/10
- SpyGlass Pharma/Governance↓[MEDIUM RISK]▼
Officer change (Item 5.02) + bylaws amendments (Item 5.03), medium risk leadership/institutional shifts
- Advantage Solutions/Agreement Terms↓[MEDIUM RISK]▼
Undisclosed material agreement (Item 1.01), medium risk unfavorable terms possible
- Glacier Bancorp/Officer Change↓[MEDIUM RISK]▼
Undisclosed 5.02 details, medium risk in bancorp-industrial ties
- Kroger/Leadership↓[MEDIUM RISK]▼
Officer change (Item 5.02) + Reg FD, medium risk supply chain industrials exposure
- Verizon/Officer Change↓[MEDIUM RISK]▼
Undisclosed director/officer event (Item 5.02), low materiality but telecom-infrastructure overlap
Opportunities(10)
- Waters Corp/Acquisition↓(OPPORTUNITY)◆
Item 2.01 completion + Item 1.01 agreement, probe exhibits for synergies/valuations in scientific instruments
- Generation Bio/M&A↓(OPPORTUNITY)◆
Change in control (Item 5.01) + acquisition, potential turnaround despite delisting, high 10/10 materiality
- SPACSphere/Merger↓(OPPORTUNITY)◆
SPAC Item 1.01 agreement + equity sales, de-SPAC alpha in industrials target hunt
- Liminatus Pharma/Partnership↓(OPPORTUNITY)◆
Material agreement financing potential, exhibits for dilution offsets
- Advantage Solutions/Material Deal↓(OPPORTUNITY)◆
Item 1.01 + Reg FD, marketing services for industrials upside
- FedEx/Events↓(OPPORTUNITY)◆
Item 8.01 disclosure, transportation sector leader for logistics rebound
- IDEX Corp/Governance↓(OPPORTUNITY)◆
Fresh officer appointment (Item 5.02), machinery firm stability play
- Phoenix Motor/Leadership Refresh↓(OPPORTUNITY)◆
Item 5.02 change, EV bus opportunity if positive hire
- Tredegar/Investor Update↓(OPPORTUNITY)◆
Reg FD + officer arrangements, industrial packaging undervalued
- Broadridge/Reg FD↓(OPPORTUNITY)◆
Item 7.01 disclosure, financial tech for industrials processing
Sector Themes(6)
- Executive Churn Epidemic◆
15/41 filings (37%) disclose Item 5.02 officer/director changes (e.g., Verizon, IDEX, Glacier), cross-sector pattern implying industrials leadership resets amid economic uncertainty, watch for performance correlations
- M&A Consolidation Wave◆
5 high-materiality filings (12%) with Items 1.01/2.01 (Waters, Generation Bio, SPACSphere), average materiality 8.6/10, signals industrials dealmaking despite no valuation data, potential for undervalued targets
- Earnings Silence◆
8/41 neutral Item 2.02 filings (Apollo, Enanta) with no YoY/QoQ metrics disclosed, typical pre-earnings blackout, portfolio trend of opacity delaying trend ID
- Reg FD Disclosure Surge◆
10+ filings (24%) under Item 7.01 (Huntington, Old National, Tredegar), voluntary info dumps likely earnings previews, aggregate file sizes >10MB suggest presentations for alpha extraction
- Neutral Sentiment Dominance◆
40/41 neutral, one mixed; no bearish metrics but undisclosed details in 20+ filings amplify uncertainty, industrials peers stable vs volatile peers
- Governance Over Financials◆
70% filings lack quantitative enriched data (no insider trades, guidance, ratios), shift focus to Item 5.xx themes for conviction proxies
Watch List(8)
High-risk mixed sentiment acquisition + delisting notice (Item 3.01), monitor trading halt Feb 10-15, 2026
- Waters Corp (23)/Acquisition👁
Post-deal financial obligation (Item 2.03) + officer change, watch Q1 earnings call for integration metrics
Medium-risk Item 5.02 undisclosed details, track board minutes for EV industrials impact Feb 2026
SPAC Item 1.01 terms undisclosed, monitor shareholder vote timeline ~Mar 2026
Item 3.02 dilution + agreement, watch share count changes post-filing
Item 8.01 low details, transportation catalyst ahead of earnings season Feb 2026
Item 5.02 governance, monitor insider follow-up filings for conviction
Item 7.01 + officer change, exhibits for industrial metrics preview
Filing Analyses(41)
09-02-2026
Apollo Global Management, Inc. filed an 8-K on February 9, 2026 (AccNo: 0001858681-26-000007), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no directional performance indicators available.
09-02-2026
Waters Corp (/DE/) filed an 8-K on February 9, 2026 (AccNo: 0001193125-26-041897, Size: 464 KB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics were explicitly stated in the filing description provided. This appears to be a standard earnings-related disclosure.
09-02-2026
PhenixFIN Corp filed a Form 8-K on February 9, 2026 (AccNo: 0001213900-26-013686), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a multi-item voluntary disclosure typical for earnings announcements.
09-02-2026
AMERICAN BATTERY TECHNOLOGY Co filed an 8-K on February 9, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the provided filing information. All quantitative financial metrics and transaction details remain NOT_DISCLOSED.
- ·Sector: not specified
- ·AccNo: 0001493152-26-005793
- ·File size: 6 MB
09-02-2026
Artificial Intelligence Technology Solutions Inc. filed an 8-K on February 09, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or quantitative data are disclosed in the provided filing information. No positive or negative metrics are mentioned.
09-02-2026
Broadridge Financial Solutions, Inc. filed a Form 8-K on February 9, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, events, or quantitative data are explicitly stated in the filing summary. The disclosure appears informational with attached exhibits of 8 MB size.
09-02-2026
PHOENIX MOTOR INC. filed an 8-K on 2026-02-09 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names of individuals, key positions affected (e.g., CEO, CFO), reasons for the change, timing, internal/external status, or any quantitative data are disclosed. Sector is not specified.
- ·Event date: February 09, 2026
- ·Filing AccNo: 0001493152-26-005679
- ·File size: 197 KB
09-02-2026
EDGEWELL PERSONAL CARE Co filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside results of operations and financial condition (Item 2.02), submission of matters to a vote of security holders (Item 5.07), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific details on the officer involved, position affected, reason for change, timing, or any quantitative financial metrics are disclosed in the provided filing summary. No positive or negative performance metrics, comparisons, or governance implications are mentioned.
09-02-2026
Advantage Solutions Inc. filed a Form 8-K on February 9, 2026, disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This multi-item filing includes both mandatory (Item 1.01) and voluntary (Item 7.01) disclosures, but specific details on the agreement, events, or exhibits are NOT_DISCLOSED. No quantitative financial metrics, transaction values, or performance comparisons are provided.
09-02-2026
FIRST BANCORP /PR/ filed an 8-K on 2026-02-09 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons, or timing were disclosed.
09-02-2026
Ocugen, Inc. filed an 8-K on 2026-02-09 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.
09-02-2026
Verizon Communications Inc filed an 8-K on 2026-02-09 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including names, positions affected, reasons for change, or quantitative data are disclosed in the provided filing summary. No positive or negative metrics are mentioned.
09-02-2026
SurgePays, Inc. filed a Form 8-K on February 9, 2026 (AccNo: 0001493152-26-005701, size: 227 KB) reporting under Item 7.01 Regulation FD Disclosure. No financial metrics, transactions, period-over-period comparisons, positive or negative changes, or other quantitative details are explicitly stated in the filing information provided. This is a single-item voluntary disclosure with no core event details, impacts, or scheduled events disclosed.
09-02-2026
FB Bancorp, Inc. /MD/ filed a Form 8-K on February 9, 2026 (AccNo: 0000943374-26-000066, Size: 683 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, exhibits, or any quantitative metrics are disclosed in the provided filing summary. This appears to be an informational disclosure without evident positive or negative financial impacts.
09-02-2026
ADDENTAX GROUP CORP. filed a Form 8-K on February 9, 2026 (AccNo: 0001493152-26-005722, size: 201 KB), reporting solely under Item 8.01 Other Events. No specific details regarding the nature of the other event, financial metrics, transactions, or impacts are disclosed in the provided filing summary. No positive or negative metrics are mentioned.
09-02-2026
Northfield Bancorp, Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, timing, or quantitative data were provided.
09-02-2026
Liminatus Pharma, Inc. filed an 8-K on February 9, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with Item 9.01 providing financial statements and exhibits. No specific details on the agreement, transaction size, financial impacts, or strategic rationale are provided in the filing summary. This is a multi-item mandatory disclosure with no quantitative metrics or period-over-period comparisons disclosed.
09-02-2026
Enanta Pharmaceuticals Inc filed an 8-K on February 9, 2026 (AccNo: 0001193125-26-042812), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the provided filing information. This constitutes a standard earnings-related disclosure without quantified financial metrics.
09-02-2026
Immucell Corp (/DE/) filed an 8-K on February 9, 2026 (AccNo: 0001437749-26-003514), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected individuals, positions, reasons, timing, or financial impacts are disclosed.
09-02-2026
09-02-2026
Kroger Co filed an 8-K on 2026-02-09 disclosing an officer or director change under Item 5.02, which includes departures, elections, appointments, and compensatory arrangements for certain officers. The filing also contains Regulation FD disclosure under Item 7.01 and lists financial statements and exhibits under Item 9.01. No specific details on positions affected, individuals involved, reasons, or financial impacts are disclosed.
09-02-2026
Waters Corp /DE/ filed an 8-K on February 09, 2026, announcing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), alongside creation of a direct financial obligation (Item 2.03). The filing also discloses changes in directors or officers including compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and includes financial statements and exhibits (Item 9.01). No specific transaction details, financial metrics, parties, or impacts are provided in the available filing information.
- ·AccNo: 0001193125-26-042819
- ·Filing Size: 3 MB
- ·Event Type: Merger/Acquisition
09-02-2026
Corebridge Financial, Inc. filed a Form 8-K on 2026-02-09 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet impacts, guidance, or period-over-period comparisons are detailed in the provided filing information. This is a standard earnings-related disclosure with all quantitative metrics NOT_DISCLOSED.
09-02-2026
SpyGlass Pharma, Inc. filed an 8-K on February 9, 2026, disclosing an officer change or departure of directors under Item 5.02 (including compensatory arrangements of certain officers), amendments to articles of incorporation or bylaws under Item 5.03, and Regulation FD disclosure under Item 7.01. No specific details on positions affected, individuals involved, reasons for changes, timing, or financial impacts are disclosed. Item 9.01 references financial statements and exhibits, but contents are NOT_DISCLOSED.
09-02-2026
OLD NATIONAL BANCORP /IN/ filed an 8-K on February 9, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), with a file size of 10 MB indicating potential attachments such as press releases or presentations. This is a multi-item filing likely involving voluntary disclosure of material nonpublic information to comply with Regulation FD, accompanied by exhibits. No specific financial metrics, transactions, events, or quantitative data are explicitly stated in the provided filing details.
09-02-2026
Associated Banc-Corp filed an 8-K on February 9, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This appears to be a voluntary disclosure to comply with Regulation FD, likely attaching investor materials such as a press release or presentation as exhibits. No specific financial metrics, transactions, or performance data are disclosed in the filing summary.
09-02-2026
Tredegar Corp filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and timing are NOT_DISCLOSED.
09-02-2026
FedEx Corp filed an 8-K on February 9, 2026, under Item 8.01 Other Events. No specific details regarding the core event, financial impacts, transactions, or metrics are disclosed in the filing summary. No quantitative data, period-over-period comparisons, positive or negative changes, or scheduled events are mentioned.
09-02-2026
IDEX Corporation (IDEX CORP /DE/) filed an 8-K on February 9, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names of individuals, reasons for changes, timing, internal/external status, or any quantitative data are disclosed. This appears to be a routine governance filing with no additional financial or operational metrics provided.
- ·AccNo: 0001193125-26-042918
- ·Filing size: 133 KB
- ·Event date: February 09, 2026
- ·Sector: not specified
09-02-2026
Designer Brands Inc. filed a Form 8-K on February 9, 2026, reporting solely under Item 8.01 Other Events. No specific details on the core event, financial impacts, transactions, metrics, or scheduled events are disclosed in the provided filing information. This is a single-item filing with no quantitative data or period-over-period comparisons mentioned.
09-02-2026
Reliance Global Group, Inc. filed a Form 8-K on 2026-02-09 (AccNo: 0001493152-26-005786, Size: 279 KB) reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the other events or the nature of any financial statements and exhibits are disclosed in the provided filing information. Critical content of the items is missing, limiting assessment of impact.
- ·Filing is multi-item 8-K (Items 8.01 and 9.01)
09-02-2026
Glacier Bancorp, Inc. filed an 8-K on February 9, 2026 (AccNo: 0000868671-26-000009, Size: 509 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, appointment or resignation status, reason for change, effective date, or any compensatory arrangements are disclosed. No quantitative financial metrics, period-over-period comparisons, scheduled events, or other numerical data are mentioned.
09-02-2026
Middlefield Banc Corp filed an 8-K on February 9, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed. This appears to be a multi-item informational filing with no quantified positive or negative impacts mentioned.
09-02-2026
Generation Bio Co. announced the completion of an acquisition or disposition of assets (Item 2.01) and a change in control of the registrant (Item 5.01), alongside entry into a new material definitive agreement (Item 1.01). However, the filing also discloses termination of a prior material definitive agreement (Item 1.02), notice of delisting or failure to satisfy listing standards (Item 3.01), and material modifications to rights of security holders (Item 3.03), signaling potential loss of public market access. Governance changes include departures or elections of directors/officers (Item 5.02) and amendments to articles of incorporation or bylaws (Item 5.03).
09-02-2026
F&M Bank Corp filed an 8-K on February 9, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for the change, timing, or any quantitative impacts are disclosed. No positive or negative metrics, financial data, or performance comparisons are mentioned in the provided information.
09-02-2026
Fifth District Bancorp, Inc. filed a Form 8-K on 2026-02-09 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer position, appointment or resignation status, reasons for change, financial metrics, or other quantitative data are disclosed. No positive or negative metrics are present to balance.
09-02-2026
SPACSphere Acquisition Corp. filed an 8-K on February 09, 2026, under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), signaling a merger or acquisition event typical for a SPAC. No quantitative metrics, deal terms, parties beyond the filer, valuations, synergies, or timelines are disclosed. No positive or negative financial changes are mentioned.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 41 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC